Roshanak Bob

501 total citations
8 papers, 259 citations indexed

About

Roshanak Bob is a scholar working on Pathology and Forensic Medicine, Genetics and Molecular Biology. According to data from OpenAlex, Roshanak Bob has authored 8 papers receiving a total of 259 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 3 papers in Genetics and 2 papers in Molecular Biology. Recurrent topics in Roshanak Bob's work include Lymphoma Diagnosis and Treatment (6 papers), Cancer Genomics and Diagnostics (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). Roshanak Bob is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Cancer Genomics and Diagnostics (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). Roshanak Bob collaborates with scholars based in Germany, Switzerland and United States. Roshanak Bob's co-authors include Harald Stein, Michael Hummel, Alfred C. Feller, Wolfram Klapper, Peter Mӧller, Annette Plütschow, Martin‐Leo Hansmann, Heinz‐Wolfram Bernd, German Ott and Dennis A. Eichenauer and has published in prestigious journals such as Blood, British Journal of Haematology and Leukemia.

In The Last Decade

Roshanak Bob

8 papers receiving 256 citations

Peers

Roshanak Bob

PFM

GENET

ONCOL

HEMAT

NEURO

Eugene Zhu United States

Catia Bigazzi Italy

Anna Schmitt France

Bianca Schuhmacher Germany

Alessandra Cuttica Italy

M. Angelopoulou Greece

Jordina Rovira Spain

Shayne Atkinson United Kingdom

Georg Lenz Germany

Willem Kraan Netherlands

Eugene Zhu United States

Roshanak Bob

155 ×0.9

PFM

123 ×0.9

GENET

164 ×1.3

ONCOL

52 ×0.8

HEMAT

42 ×0.8

NEURO

Citations per year, relative to Roshanak Bob Roshanak Bob (= 1×) peers Eugene Zhu

Countries citing papers authored by Roshanak Bob

Since Specialization

Citations

This map shows the geographic impact of Roshanak Bob's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roshanak Bob with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roshanak Bob more than expected).

Fields of papers citing papers by Roshanak Bob

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roshanak Bob. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roshanak Bob. The network helps show where Roshanak Bob may publish in the future.

Co-authorship network of co-authors of Roshanak Bob

This figure shows the co-authorship network connecting the top 25 collaborators of Roshanak Bob. A scholar is included among the top collaborators of Roshanak Bob based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roshanak Bob. Roshanak Bob is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Stein, H, Roshanak Bob, Horst Dürkop, et al.. (2015). A new monoclonal antibody (CAL2) detects CALRETICULIN mutations in formalin-fixed and paraffin-embedded bone marrow biopsies. Leukemia. 30(1). 131–135. 22 indexed citations

2.

Kvasnicka, Hans Michael, Christine Beham‐Schmid, Roshanak Bob, et al.. (2015). Problems and pitfalls in grading of bone marrow fibrosis, collagen deposition and osteosclerosis – a consensus‐based study. Histopathology. 68(6). 905–915. 59 indexed citations

3.

Hartmann, Sylvia, Dennis A. Eichenauer, Annette Plütschow, et al.. (2014). Histopathological features and their prognostic impact in nodular lymphocyte‐predominant Hodgkin lymphoma – a matched pair analysis from the German Hodgkin Study Group (GHSG). British Journal of Haematology. 167(2). 238–242. 33 indexed citations

4.

Hartmann, Sylvia, Dennis A. Eichenauer, Annette Plütschow, et al.. (2013). The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG). Blood. 122(26). 4246–4252. 112 indexed citations

5.

Bob, Roshanak, Brunangelo Falini, Teresa Marafioti, et al.. (2013). Nodal reactive and neoplastic proliferation of monocytoid and marginal zone B cells: an immunoarchitectural and molecular study highlighting the relevance of IRTA1 and T‐bet as positive markers. Histopathology. 63(4). 482–498. 23 indexed citations

6.

Barth, Thomas F.E., Roshanak Bob, Sergio Cogliatti, et al.. (2012). Ringversuch zum Nachweis genomischer Veränderungen bei Non-Hodgkin-Lymphomen mittels In-situ-Hybridisierung. Der Pathologe. 34(4). 329–334. 5 indexed citations

7.

Stein, Harald & Roshanak Bob. (2009). Is Hodgkin lymphoma just another B-cell lymphoma?. Current Hematologic Malignancy Reports. 4(3). 125–128. 4 indexed citations

8.

Wilkinson, Sarah T., Roshanak Bob, Harald Stein, et al.. (2009). A Comparison of Gene Expression Pattern in Major Histocompatibility Class II-Low Diffuse Large B-Cell Lymphoma with Plasmablastic Lymphoma.. Blood. 114(22). 1941–1941. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact